11/03/2014 - 10:25am

Protein Sciences Corp. last week announced that the Food and Drug Administration approved Flublok influenza vaccine for all adults ages 18 years and older.

10/31/2014 - 12:15pm

Treasury Department aide Alastair “Al” Fitzpayne has been tapped as the Department of Health and Human Services’ next chief of staff, the Wall Street Journal reported.

10/30/2014 - 11:54am

AstraZeneca on Thursday announced that the Food and Drug Administration approved Xigduo XR (dapagliflozin and metformin hydrochloride extended-release), a once-daily drug for the treatment of adults with Type 2 diabetes. 

10/27/2014 - 10:16am

The National Association of Drug Diversion Investigators on Friday highlighted the latest results achieved by Alabama's real-time, stop-sale pseudoephedrine tracking system.

10/24/2014 - 8:57am

Pfizer on Thursday announced that the U.S. District Court for the District of Delaware upheld its basic patent and the L-malate salt patent covering Sutent (sunitinib malate) capsules.

10/22/2014 - 1:50pm

The Food and Drug Administration last week announced plans to survey pharmacists and patients about their experiences resulting from changes in generic drug pill appearance.

10/22/2014 - 11:20am

Pfizer last week announced that the Food and Drug Administration approved a revised label for Embeda (morphine sulfate and naltrexone hydrochloride) extended-release capsules, for oral use, CII, to include abuse-deterrence studies. 

 

10/22/2014 - 8:06am

A JAMA study noted that about two-thirds of dietary supplements recalled by the Food and Drug Administration still contained banned ingredients at least six months after being recalled.

10/17/2014 - 1:58pm

The Congressional Dietary Supplement Caucus hosted an educational briefing and luncheon for congressional staffers on Oct. 14, the day before the 20th anniversary of the passage of the Dietary Supplement Health and Education Act.